Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
DocuSign's 2026 earnings narrative centers on ARR expansion, margin discipline, and stronger cash flow in a competiti...
Microsoft stock slid about 25% in Q1 2026, its worst showing in years, as AI spending accelerates yet revenue signals...
MicroStrategy stock has jumped 43% in the last month as Bitcoin climbs. A new strategy price prediction: mstr model s...
During 13F season, big investors reveal shifts in their portfolios. This piece explains the move, why Microsoft was f...
The spmc 2026 earnings call offers a clear view of growth, margins, and cash flow. This article breaks down the highl...
Oil markets look calm, but important shifts are quietly unfolding near the Strait of Hormuz. This article explains wh...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
A Daiwa Securities analyst labeled SpaceX’s valuation catastrophic, while options traders bought calls, signaling a b...
Warren Buffett is famous for value investing and extraordinary generosity. This article examines a potential new targ...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
As Ranpak tackles 2025 earnings, investors watch for sustainable packaging demand, margin discipline, and cash flow r...